Cargando…

Costs related to immunopreventable diseases: Brazil and its geographic areas (immunopreventable diseases’ costs in Brazil)

INTRODUCTION: The occurrence of the immunopreventable diseases in a population global reality. OBJECTIVE: To discriminate the direct costs of the hospitalizations from the immunopreventable diseases in the Unified Health System (SUS), in Brazil and their areas, between 2008 and 2018. METHODS: A popu...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Costa, Élide Sbardellotto M., Hyeda, Adriano, Maluf, Eliane M. C. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555006/ https://www.ncbi.nlm.nih.gov/pubmed/34706728 http://dx.doi.org/10.1186/s12913-021-07117-5

Ejemplares similares

Hospital costs of immunopreventable diseases in the economically active population in Brazil
por: da Costa, Élide Sbardellotto M., et al.
Publicado: (2021)

Economic analysis of costs with enteral and parenteral nutritional therapy according to disease and outcome
por: Hyeda, Adriano, et al.
Publicado: (2017)

Immunoprevention approaches for cancer prevention
por: Umar, Asad
Publicado: (2014)

Cancer Immunoprevention and Public Health
por: Singh, Sandeep K., et al.
Publicado: (2017)

An Overview of Cancer Prevention: Chemoprevention and Immunoprevention
por: Gu, Kyle J., et al.
Publicado: (2020)

The Negative Impact of the New Coronavirus Pandemic on the Trend of Breast Biopsies and Their Direct Costs: Interrupted Time Series Analysis
por: Hyeda, Adriano, et al.
Publicado: (2023)

COVID-19: The Need for Immunoprevention at Industrial Scale
por: Halstead, Scott B.
Publicado: (2020)

The trend and direct costs of screening and chemotherapy treatment of breast cancer in the new coronavirus pandemic: total and interrupted time series study
por: Hyeda, Adriano, et al.
Publicado: (2022)

Modelling vaccination schedules for a cancer immunoprevention vaccine
por: Motta, Santo, et al.
Publicado: (2005)

Cancer immunoprevention: from mice to early clinical trials
por: Palladini, Arianna, et al.
Publicado: (2018)

Vaccines for immunoprevention of DNA mismatch repair deficient cancers
por: Hernandez-Sanchez, Alejandro, et al.
Publicado: (2022)

Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review
por: Koyande, Navami Prabhakar, et al.
Publicado: (2022)

Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention
por: Centuori, Sara M., et al.
Publicado: (2021)

Immunoprevention of Basal Cell Carcinomas with Recombinant Hedgehog-interacting Protein
por: Vogt, Annika, et al.
Publicado: (2004)

Health Disparities in the Immunoprevention of Human Papillomavirus Infection and Associated Malignancies
por: Bakir, Amira H., et al.
Publicado: (2015)

Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
por: Pan, Jing, et al.
Publicado: (2017)

Vaccination-Based Immunoprevention of Colorectal Tumors: A Primer for the Clinician
por: Jackson, Katy, et al.
Publicado: (2022)

Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR‐Driven Lung Cancer
por: Huang, Mofei, et al.
Publicado: (2022)

Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches
por: Emran, Talha Bin, et al.
Publicado: (2022)

Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies
por: Sei, Shizuko, et al.
Publicado: (2023)

A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention
por: Chen, Jie, et al.
Publicado: (2019)

Toxoplasma Rhoptries: Unique Secretory Organelles and Source of Promising Vaccine Proteins for Immunoprevention of Toxoplasmosis
por: Dlugonska, Henryka
Publicado: (2008)

Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis
por: Croci, Stefania, et al.
Publicado: (2015)

Moving Immunoprevention Beyond Virally Mediated Malignancies: Do We Need to Link It to Early Detection?
por: Dhodapkar, Madhav V., et al.
Publicado: (2019)

Targeting IL-1β as an immunopreventive and therapeutic modality for K-ras–mutant lung cancer
por: Yuan, Bo, et al.
Publicado: (2022)

Targeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast Cancer
por: Tuohy, Vincent K., et al.
Publicado: (2016)

Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper
por: Driggers, Lara, et al.
Publicado: (2009)

Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention
por: Lee, Sang Beom, et al.
Publicado: (2023)

Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer
por: Annapragada, Ananth, et al.
Publicado: (2020)

OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis
por: Nanni, Patrizia, et al.
Publicado: (2018)

Epithelial Mutant p53 Promotes Resistance to Anti-PD-1-Mediated Oral Cancer Immunoprevention in Carcinogen-Induced Mouse Models
por: Wang, Jin, et al.
Publicado: (2021)

The direct and indirect costs of cardiovascular diseases in Brazil
por: de Araújo, Jevuks Matheus, et al.
Publicado: (2022)

Cost-effectiveness analysis of the treatment of mild and moderate Alzheimer’s disease in Brazil
por: da Silva, Luciana R., et al.
Publicado: (2018)

Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil
por: Ubels, Jasper, et al.
Publicado: (2020)

Improving the serodiagnosis of canine Leishmania infantum infection in geographical areas of Brazil with different disease prevalence
por: Ramírez, Laura, et al.
Publicado: (2019)

Cost of providing doctors in remote and vulnerable areas: Programa Mais Médicos in Brazil
por: da Silva, Everton Nunes, et al.
Publicado: (2018)

Geographical heterogeneity in the analysis of factors associated with leprosy in an endemic area of Brazil: are we eliminating the disease?
por: Duarte-Cunha, Mônica, et al.
Publicado: (2015)

Annual Direct Medical Costs of Diabetic Foot Disease in Brazil: A Cost of Illness Study
por: Toscano, Cristiana M., et al.
Publicado: (2018)

Cost-related underuse of medications in older adults: ELSI-Brazil
por: de Loyola, Antônio Ignácio, et al.
Publicado: (2018)

Stage-Related Cost of Treatment of Bladder Cancer in Brazil
por: Korkes, Fernando, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4igr3dngindk6fumjtnri15uv6